🔗 Visit the ClinicalTrials.gov page for NCT02521792
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists. | Nat Med | 2011 | 2.40 |
| 2 | Towards a cure for Fibrodysplasia ossificans progressiva. | Ann Transl Med | 2016 | 0.75 |